BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12756826)

  • 1. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How to establish GCP-units in Denmark?].
    Krogsgaard K; Andreasen PB
    Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of the GCP guidelines in Europe.
    Geussenhainer S
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good clinical practice is now obligatory in academic clinical drug research in the European Union.
    Jørgensen A; Bach KF; Friis K
    Basic Clin Pharmacol Toxicol; 2004 Feb; 94(2):57-8. PubMed ID: 14748847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent changes in quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Fujimura A
    Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The GCP-unit at the Aaarhus University Hospital].
    Jørgensen A; Fabricius S; Nexø E; Djurhuus JC; Rosenberg R; Hammer U; Christiansen JS
    Ugeskr Laeger; 2000 Aug; 162(32):4288-90. PubMed ID: 10962954
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
    Legler UF
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transplantation in children: how to design a new study.
    Corbacioglu S;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reporting adverse reactions and events in randomised clinical trials].
    Hemmingsen B; Støy L; Wetterslev J; Tarnow L; Friis KB; Christensen LL; Sales N; Gluud C;
    Ugeskr Laeger; 2010 Aug; 172(35):2381-4. PubMed ID: 20825743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organization, administration, and performance of clinical studies].
    Bachner M; Steininger T; Gneist M
    Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCP data quality for early clinical development.
    Rock EP; Molloy VJ; Humphrey JS
    Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the GCP Directive on academic drug trials].
    Berendt L; Håkansson C; Bach KF; Dalhoff K; Andreasen PB; Petersen LG; Andersen E; Poulsen HE
    Ugeskr Laeger; 2008 Aug; 170(33):2437-9. PubMed ID: 18761825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.